Aligos Therapeutics (ALGS) Capital Expenditures (2019 - 2023)
Aligos Therapeutics' (ALGS) quarterly Capital Expenditures came in at $7000.0 in Q1 2023, down 98.64% YoY from $515000.0 in Q1 2022, and down 92.31% on a QoQ basis from $91000.0 in Q4 2022.
Aligos Therapeutics (ALGS) Capital Expenditures (2019 - 2023) Analysis & Trends
Aligos Therapeutics (ALGS) has 5 years of Capital Expenditures data on file, last reported at $7000.0 in Q1 2023.
- Quarterly Capital Expenditures fell 98.64% year-over-year to $7000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $435000.0 (up 95.07% YoY) and the FY2024 annual result came in at $130000.0, up 584.21% from the prior year.
- Capital Expenditures fell to $7000.0 in Q1 2023, from $91000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.0 million in Q3 2020 to a low of -$1.9 million in Q4 2020.
- A 5-year average of $126285.7 and a median of $124500.0 in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2020 — Capital Expenditures slumped 366.44% — and 2021, when it soared 140.32%.
- Tracing ALGS's Capital Expenditures over 5 years: stood at $721000.0 in 2019, then tumbled by 366.44% to -$1.9 million in 2020, then surged by 71.84% to -$541000.0 in 2021, then surged by 116.82% to $91000.0 in 2022, then plunged by 92.31% to $7000.0 in 2023.
- The last three Capital Expenditures figures came in at $7000.0 (Q1 2023), $91000.0 (Q4 2022), and $3000.0 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 251.02 Mn |
| 10 | Aligos Therapeutics | 69.16 Mn | 38.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 91,000.00 |
| Dec 31, 2022 | 91,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 334,000.00 |
| Jun 30, 2022 | 334,000.00 |
| Mar 31, 2022 | 515,000.00 |
| Mar 31, 2022 | 515,000.00 |
| Dec 31, 2021 | -541,000.00 |
| Dec 31, 2021 | -541,000.00 |
| Sep 30, 2021 | 97,000.00 |
| Sep 30, 2021 | 97,000.00 |
| Jun 30, 2021 | 152,000.00 |
| Jun 30, 2021 | 152,000.00 |
| Mar 31, 2021 | 307,000.00 |
| Mar 31, 2021 | 307,000.00 |
| Dec 31, 2020 | -1.92 Mn |
| Dec 31, 2020 | -1.92 Mn |